Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study

已完结 10 由上上签发布于 2025/12/21 13:35:49

DOI:10.1038/s41440-023-01326-7
作者：Jin Zhang,?Wei Zhang,?Jie Yan,?Qian Ge,?Xiao-Hong Lu,?Shao-Xing Chen,?Wen-Jie Xu,?Ying Li,?Jin-Feng Li,?Shi-Ying He,?Ji-Guang Wang
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：This randomized, double-blind phase 2 study assessed the efficacy and safety of sacubitril/allisartan, an angiotensin receptor neprilysin inhibitor, compared with placebo in Chinese patients

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:BMJGlobal, regional and national burden of major blindness-associated ophthalmologic conditions, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021